<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112572">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01834066</url>
  </required_header>
  <id_info>
    <org_study_id>00101</org_study_id>
    <nct_id>NCT01834066</nct_id>
  </id_info>
  <brief_title>Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy</brief_title>
  <acronym>mdp</acronym>
  <official_title>Safety and Efficacy of Bone Marrow Autologous Cells in Muscular Dystrophy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaitanya Hospital, Pune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaitanya Hospital, Pune</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Study is single arm, single centre trial to check the safety and efficacy of Bone
      Marrow derived autologous cell(100 million per dose) for the patient with Duchenne Muscular
      Dystrophy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscular dystrophy is a group of inherited disorders that involve muscle weakness and loss
      of muscle tissue, which get worse over time. Duchenne muscular dystrophy is caused by a
      defective gene for dystrophin (a protein in the muscles). However, it often occurs in people
      without a known family history of the condition. slowly progress diseases.it causes Muscle
      weaknesses, Difficulty with motor skills ,Progressive difficulty walking.Breathing
      difficulties and heart disease,Frequent falls,weak limbs,lose motor Function.Begins in the
      legs and pelvis, but also occurs less severely in the arms, neck, and other areas of the
      body.Trouble getting up from a lying position or climbing stairs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Significant Improvement in Muscle strength by using Kinetics Muscle testing or by using MMT( manual muscle test }score</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>-Improvement of daily living scale and baseline in EMG(electromyography)</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Muscular Dystrophy</condition>
  <condition>Duchenne Muscular Dystrophy,</condition>
  <arm_group>
    <arm_group_label>STEM CELL</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intra thecal transplantation of autologous Stem Cell MNCs</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Stem Cell</intervention_name>
    <description>Intralesional transfer of Autologous Stem cell (MNCs) per dose. 6 doses in 3 months</description>
    <arm_group_label>STEM CELL</arm_group_label>
    <other_name>Intravenous transfer of Autologous Stem Cell ( MNCs )</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with Diagnose of Duchenne Muscular Dystrophy.

          -  Aged in between 6 to 25 Years.

          -  Willingness to undergo Bone Marrow derived Autologous cell Therapy.

          -  Ability to comprehend the explained protocol and thereafter give an informed
             consent as well as sign the required Informed Consent form(ICF) for the study.

          -  Ability and willingness to regular visit to hospital for protocol procedures and
             follow up

        Exclusion Criteria:

          -  Patient who is not Diagnose of Duchenne Muscular Dystrophy.

          -  Patient with History of Immunodeficiency  HIV+,Hepatitis B ,HBV and   TPPA+,Tumor
             Markers+

          -  History of Life threatening  allergic or immune -Mediated Reaction.

          -  the site of bone marrow aspiration potentially limiting Procedure.

          -  Alcohol and drug abuse / dependence.

          -  Patients with History of Hypertension and Hypersensitive.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ANANT E BAGUL, MS ORTHO</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHAITANYA HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachin P Jamadar, D.Ortho</last_name>
    <phone>+918888788880</phone>
    <email>sac2751982@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Smita S Bhoyar, B.A.M.S.PGCR</last_name>
    <phone>9372620569</phone>
    <email>drsmitabhoyar@rediff.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chaitnany Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411009</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin P Jamadar, D ORTHO</last_name>
      <phone>+918888788880</phone>
      <email>sac2751982@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Smita S Bhoyar, BAMS.PGCR</last_name>
      <phone>9372620569</phone>
      <email>drsmitabhoyar@rediffmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>ANANT E BAGUL, MS ORTHO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 15, 2013</lastchanged_date>
  <firstreceived_date>February 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaitanya Hospital, Pune</investigator_affiliation>
    <investigator_full_name>Dr. Sachin Jamadar</investigator_full_name>
    <investigator_title>C0-  Investigator</investigator_title>
  </responsible_party>
  <keyword>muscular Dystrophy stem cell</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
